|
ADMA | Adma Biologics, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 0.16 |
| Leverage | 23.54% |
| Market Cap | $ 3.0B |
| PE | 20.51 |
| Dividend Yield | 0.00% |
| Profit | $ 147.1m |
| Margin | 28.94% |
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.